Therefore, introducing endogenous SOD into CDT as a •OH generator would be a multifunctional catalytic therapy strategy to specifically kill tumor cells by oxidative damage while protect normal tissues against oxidative stress, which would be remarkably attractive in cancer therapy. This evidence concerns the gene SOD1 and neoplasm.